« The Urgency to Treat Optimally and to Target: Avoiding Long-Term Complications in Type 2 Diabetes With a Focus on GLP-1 Receptor Agonists ». Canadian Primary Care Today 1, no. S07 (juillet 12, 2023): 2–6. Consulté le avril 8, 2026. https://canadianprimarycaretoday.com/article/view/1-s07-noronha.